Context
KKR, through its vehicle Project Aurora Bidco Limited, has completed the acquisition of Spectris plc for a total consideration of approximately £4.4 billion. The transaction followed a competitive bidding war between KKR and Advent International. The strategic rationale for the deal is to transition Spectris to private ownership to provide the capital and flexibility needed for accelerated investment in R&D and bolt-on acquisitions. KKR has committed to maintaining Spectris’s headquarters in the UK and continuing its ESG initiatives, including a £1 million annual contribution to the Spectris Foundation. The deal allows Spectris to continue its transformation into a "world-class" precision measurement leader without the short-term pressures of the public market. The transaction was implemented via a court-sanctioned scheme of arrangement.
This platform was built through multiple acquisitions, including Micromeritics Instrument Corporation (2024) and Piezocryst Advanced Sensorics (2024), illustrating an active consolidation strategy.
SPECTRIS, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Industry & Manufacturing sector (11.5x).
-> Deep-dive in Industry & Manufacturing market trends
Target
Spectris is a leading supplier of precision instrumentation and controls. Its Malvern Panalytical division specializes in the analysis of materials' chemical, physical, and structural properties. The group focuses on high-value segments like pharma, semiconductor, and primary materials.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (GBP)
Other operations with SPECTRIS
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2024 | SPECTRIS | PIEZOCRYST ADVANCED SENSORICS | AUSTRIA | Instrumentation & Measurement |
| 07/2024 | SPECTRIS | SCIAPS INCORPORATED | UNITED STATES | Lab & Scientific Equipment |
| 07/2024 | SPECTRIS | MICROMERITICS INSTRUMENT CORPORATION | UNITED STATES | Lab & Scientific Equipment |
| 05/2022 | SPECTRIS | DYTRAN INSTRUMENTS | UNITED STATES | Sensors & Optics |
| 07/2021 | SPECTRIS | CONCURRENT REAL-TIME | UNITED STATES | Engineering & Design Software |
| 01/2018 | SPECTRIS | CONCEPT LIFE SCIENCES | UNITED KINGDOM | CRO / Clinical Trials |
REFERENCES
Valuation range: EV 3b - 100b GBP
Revenue range: 750M - 1.3b GBP
EBITDA range: 150M - 250M GBP
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SPECTRIS by KKR are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Target: spectris
Acquirer: kkr